首页> 外文期刊>Biomedicine & preventive nutrition >Antidiabetic, hypolipidemic and histopathological analysis of Gymnema sylvestre (R. Br) leaves extract on streptozotocin induced diabetic rats
【24h】

Antidiabetic, hypolipidemic and histopathological analysis of Gymnema sylvestre (R. Br) leaves extract on streptozotocin induced diabetic rats

机译:匙Gym藤叶片提取物对链脲佐菌素诱导的糖尿病大鼠的降糖,降血脂和组织病理学分析

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To investigate antidiabetic, hypolipidemic histopathological analysis of Gymnema sylvestre methanolic extract (GSME) in streptozotocin induced diabetic rat by administering oral doses (100, 200 and 400. mg/kg body weight). Methods: Blood glucose levels were measured using blood glucose test strips with elegance glucometer on weekly intervals till the end of study (i.e. four weeks). Blood glucose, urine sugar, triglycerides (TG), low density lipoprotein (LDL), high density lipoprotein (HDL) and very low density lipoprotein (VLDL) were determined in normal and streptozotocin induced diabetic rats after oral administration of the extract for 28 days. Histopathological changes in diabetic rat organs (pancreas, liver, and kidney) were also observed after extract treatment. Results: Daily oral administration GSME (100, 200 and 400. mg/kg body weight) and glibenclamide (5. mg/kg) showed beneficial effects on blood glucose level (P<. 0.01) and hyperlipidaemia due to diabetes. The extract treatment also showed to enhance serum insulin level and body weight of diabetic rats as compared to diabetic control group. Furthermore, the extract has a favorable effect on the histopathological studies, in streptozotocin induced diabetes. Conclusions: G. sylvestre possesses antidiabetic property as well improve body weight, and total lipid levels. GSME has also favorable effect to inhibit the histopathological changes in streptozotocin-induced diabetes.
机译:目的:通过口服剂量(100、200和400. mg / kg体重)研究链霉菌甲醇提取物(Gymnema sylvestre甲醇提取物)的抗糖尿病,降血脂的组织病理学分析。方法:每周至研究结束(即四周),使用带有血糖仪的血糖试纸和优雅血糖仪测量血糖水平。在正常和链脲佐菌素诱导的糖尿病大鼠中,口服提取物28天后,测定了血糖,尿糖,甘油三酸酯(TG),低密度脂蛋白(LDL),高密度脂蛋白(HDL)和极低密度脂蛋白(VLDL)。 。提取物处理后,还观察到糖尿病大鼠器官(胰腺,肝脏和肾脏)的组织病理学变化。结果:每日口服GSME(100、200和400. mg / kg体重)和glibenclamide(5。mg / kg)显示出对糖尿病引起的血糖水平(P <.0.01)和高脂血症的有益作用。与糖尿病对照组相比,提取物处理还显示出增强了糖尿病大鼠的血清胰岛素水平和体重。此外,该提取物在链脲佐菌素诱发的糖尿病中对组织病理学研究具有有利作用。结论:樟子松具有抗糖尿病作用,并且可以改善体重和总脂质水平。 GSME还具有抑制链脲佐菌素诱导的糖尿病的组织病理学变化的良好作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号